China’s medtech industry is facing complex new challenges. To meet them, companies need to cultivate adaptable and diverse leaders who can shape local solutions.
Egon Zehnder recently invited CTOs from top U.S. biopharma companies to discuss their experiences and best practices in today’s rapidly changing environment
The Egon Zehnder Health team are focused on areas of critical importance to its global health and well-being clients, including consumer centricity, data and technology and science, product innovation, global healthcare systems.
You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.